2021
DOI: 10.1016/j.bbih.2021.100303
|View full text |Cite
|
Sign up to set email alerts
|

Transdiagnostic biomarker approaches to mental health disorders: Consideration of symptom complexity, comorbidity and context

Abstract: Depression is a multifaceted disorder characterized by heterogeneous symptom profiles and high rates of comorbidity with other commonly occurring mental illnesses. Considering the burden of mental health disorders and the lack of efficacy of available treatments, there is a need for biomarkers to predict tailored or personalized treatments. However, identifying reliable biomarkers for complex mental illnesses, such as depression, anxiety and PTSD, has been challenging, likely owing to the heterogeneity, comorb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 86 publications
0
10
0
Order By: Relevance
“…Together, the variability in symptom profiles and comorbid features across disorders can impede treatment efficacy [ 5 ]. With approximately only one-third of individuals receiving an antidepressant treatment reaching remission [ 6 ], a better understanding of the neurobiology of complex mental health disorders is needed, which reflects the heterogeneity and comorbidity that exists [ 7 , 8 ]. To address this need, the Research Domain Criteria (RDoC) introduced by the US National Institute of Mental Health, is focused on shifting biomarker research away from the constraints of diagnostic categories in an effort to identify the neurobiology of dimensions that cut across disorders [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Together, the variability in symptom profiles and comorbid features across disorders can impede treatment efficacy [ 5 ]. With approximately only one-third of individuals receiving an antidepressant treatment reaching remission [ 6 ], a better understanding of the neurobiology of complex mental health disorders is needed, which reflects the heterogeneity and comorbidity that exists [ 7 , 8 ]. To address this need, the Research Domain Criteria (RDoC) introduced by the US National Institute of Mental Health, is focused on shifting biomarker research away from the constraints of diagnostic categories in an effort to identify the neurobiology of dimensions that cut across disorders [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…There is evidence that shifting biomarker research away from the constraints of diagnostic categories can effectively differentiate dimensions that cut across disorders according to neurobiology, which has implications for informing personalized or tailored treatments [ 8 , 9 , 17 ]. Thus, the current investigation focused on characterizing meaningful subtypes (i.e., clusters) of individuals according to depressive and anxiety symptomatologies, and explored whether peripheral biomarkers, including cortisol, CRP, IL-6, and TNF-α levels could be used to differentiate symptom clusters.…”
Section: Introductionmentioning
confidence: 99%
“…However, the plausible impact of narcissistic traits on psychological adjustment in relation to other traumatic experiences, and therefore the presence of post-traumatic symptoms, has rarely been [17,18]. Moreover, despite the proven utility of the transdiagnostic approach in the treatment of mental health problems [5,[34][35][36], and the mixed results regarding the relationship between the two types of narcissism (Vulnerable vs. Grandiose) and mental health adjustment, few studies have focused on their individual constituents, especially with respect to grandiose narcissism dimensions, the effects of which on health outcomes and self-regulation seem to be mediated by a positive outlook [32,33].…”
Section: Introductionmentioning
confidence: 99%
“…Depressive symptomatology is a transdiagnostic feature frequently comorbid in psychiatric disorders, with highly heterogeneous symptoms, typically physical and emotional-cognitive symptoms encompassing feelings of worthlessness, guilt, shame, lowered selfesteem, and hopelessness. Heterogeneity and comorbidity of depression symptoms impact the response to first-line treatment [1][2][3][4], contributing to higher suicide risk. Some authors consider mental pain a part of depression, although doubts still exist about a clear distinction between major depression and mental pain [5,6].…”
Section: Introductionmentioning
confidence: 99%